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Probable mechanisms of regulation of the utilization of dietary 
tryptophan, nicotinamide and nicotinic acid as precursors of 
nicotinamide nucleotides in the rat 
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I .  The regulation of the utilization of dietary tryptophan, nicotinamide and nicotinic acid as precursors of the 
nicotinamide nucleotides has been studied in groups of rats fed on diets providing only one of these precursors 
at a time, in amounts adequate to meet their requirements for nucleotide synthesis. 
2. The concentration of nicotinamide nucleotides in the liver of rats receiving a high-tryptophan diet was 56% 
higher than in animals fed on a diet providing a minimum amount of tryptophan, together with nicotinic acid 
or nicotinamide. The excretion of W-methyl nicotinamide was three times higher in the tryptophan-fed animals 
than in the other two groups. 
3. The concentration of quinolinic acid in the liver was significantly higher in animals receiving the 
high-tryptophan diet than in the other two groups; that of nicotinic acid was highest in those animals receiving 
the nicotinic-acid-containing diet. The concentration of nicotinamide was highest in the livers of those animals 
receiving the high-tryptophan diet, and lowest in those receiving the nicotinic-acid-containing diet. 
4. The values of the Michaelis constant K ,  of nicotinamide deamidase (nicotinamide ainidohydrolase, 
EC 3 . 5 .  I .19) and nicotinamide phosphoribosyltransferase (nicotinamide nucleotide: pyrophosphate phos- 
phoribosyltransferase, EC2.4 .2 .12)  were approximately equal, and approximately one-tenth of the concentration 
of nicotinamide was in the liver. This suggests that both these enzymes normally function at their maximum rate, 
and a change in the availability of nicotinamide would not affect the rate of its incorporation into nucleotides. 
5. The maximum rate of reaction (VmaX) of nicotinamide deamidase was twice that of nicotinamide 
phosphoribosyltransferase; this suggests that unless compartmental or other factors are involved, the major route 
of nicotinamide utilization will be by way of deamidation. 
6. The K ,  of nicotinate phosphoribosyltransferase (nicotinate nucleotide : pyrophosphate phosphoribosyltrans- 
ferase, EC 2 . 4 . 2 .  11) was less than twice the concentration of nicotinic acid in the liver, so that a change in the 
availability of nicotinic acid might be expected to lead to a small change in the rate of its utilization. 
7.  The K, of quinolinate phosphoribosyltransferase (nicotinate nucleotide : pyrophosphate phosphoribosyl- 
transferase (carboxylating) EC 2 . 4 . 2 . 1 9 )  was approximately 100 times greater than the concentration of 
quinolinic acid in the liver, so that any change in the availability of quinolinic acid would be expected to lead 
to a considerable change in the rate of its utilization. The V,,, of quinolinate phosphoribosyltransferase was 
relatively low, so that under conditions of high tryptophan flux, some accumulation of quinolinic acid might be 
expected. This was observed in animals receiving the high-tryptophan diet. 
8.  It is concluded that it is unlikely that the utilization of quinolinic acid, arising from tryptophan, for the 
synthesis of nicotinamide nucleotides is regulated, but that control over tissue concentrations of nucleotides is 
achieved by hydrolysis of NAD to nicotinamide. Incorporation of nicotinamide into nucleotides seems to be strictly 
limited by the activity of the enzymes involved. 
Both the amino acid tryptophan and the niacin vitamers, nicotinamide and nicotinic acid, 
can act as precursors of the nicotinamide nucleotides, NAD and NADP. The relevant 
pathways are shown in Fig. 1. 
Gadd & Johnson (1  974) suggested that most dietary niacin is present as nicotinamide 
rather than as the acid, although they did not cite any reference for this statement. The 
amide is also the immediate product of the hydrolysis of tissue nicotinamide nucleotides, 
catalysed by NADase (NAD glycohydrolase, EC 3 . 2 . 2 . 5 ) .  This nicotinamide may either 
be available for the synthesis of nicotinamide nucleotides, or it may be methylated to 
N-methyl nicotinamide and excreted. 
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Fig. 1. Pathways of nicotinamide nucleotide synthesis and metabolism. (1) Tryptophan oxygenase 
(L-tryptophan: oxygen oxido-reductase, EC 1 . 13.1 . 12); (2) picolinate carboxylase (3’-oxo-prop-2- 
amino-but-2-ene dioate carboxylase, EC 4 .1  . 1 .45); (3) quinolinate phosphoribosyltransferase (nico- 
tinate nucleotide :pyrophosphate phosphoribosyltransferase (carboxylating), EC 2.4 .2 .19) ;  (4) 
nicotinate phosphoribosyltransferase (nicotinate nucleotide : pyrophosphate phosphoribosyltransferase, 
EC 2.4 .2 .  I I); (5) nicotinamide phosphoribosyltransferase (nicotinamide nucleotide : pyrophosphate 
phosphoribosyltransferase, EC 2.4.2.12);  (6) nicotinamide deamidase (nicotinamide amido-hydrolase, 
EC 3.5.  I . 19); (7) NADase (NAD glycohydrolase, EC 3.2.2.5); (8) nicotinamide N-rnethyltransferase 
(S-adenosyl-methionine : nicotinamide N-methyltransferase, EC 2.1 . 1 . 1). 
There is disagreement about the relative importance of the two possible routes of 
utilization of nicotinamide for nucleotide synthesis : direct incorporation in a reaction 
catalysed by nicotinamide phosphoribosyltransferase (nicotinamide nucleotide : pyrophos- 
phate phosphoribosyltransferase, EC 2 . 4 . 2 .  12) or deamidation to nicotinic acid catalysed 
by nicotinamide deamidase (nicotinamide amidohydrolase, EC 3 . 5 .  1 . 19), followed by 
incorporation into nicotinic acid nucleotide, catalysed by nicotinate phosphoribosyltrans- 
ferase (nicotinate nucleotide :pyrophosphate phosphoribosyltransferase, EC 2.4.2.11). 
Petrack et al. (1  963) showed that there was adequate activity of nicotinamide deamidase 
in rat liver to account for the utilization of all the normal dietary intake of nicotinamide, 
without any requirement for a phosphoribosyltransferase. However, Grunicke et al. (1 974), 
working with perfused rat liver, showed direct incorporation of [14C]nicotinamide into 
NAD, with no labelling of nicotinic acid or desamido-NAD. Delabar & Siess (1979) 
obtained a similar result when isolated guinea-pig atria were incubated with a low (10 ,UM) 
concentration of nicotinamide. When the concentration of nicotinamide was increased 
to 20 mM, they showed that deamidation became an important route of utilization. 
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It is not known whether the size of the tissue pools of nicotinamide nucleotides is regulated 
primarily by control of the utilization of the precursors (nicotinic acid, nicotinamide and 
quinolinic acid), and therefore by regulation of the activities of the phosphoribosyltrans- 
ferases and nicotinamide deamidase, or whether control is by variation of the activity of 
NADase, and hence catabolism of nucleotides formed in excess of requirements. 
In the present study we have attempted to define regulatory steps in the synthesis of 
nicotinamide nucleotides from the three possible dietary sources, and also to clarify the 
relative importance of the two possible routes of nicotinamide utilization (deamidation and 
direct incorporation into nucleotides). Rats were fed on diets providing their niacin require- 
ments from each of the precursors separately, and tissue concentrations of nucleotides and 
precursors, urinary excretion of An-methyl nicotinamide and the activities of the enzymes 
involved were assessed. The results suggest regulation of the utilization of nicotinamide and 
nicotinic acid, but not of quinolinic acid, arising from the oxidative metabolism of 
tryptophan. 
METHODS 
Animals and diets 
Male Wistar rats, bred in the Courtauld Institute, were used. At 21 d after birth they were 
weaned onto one of the experimental diets described, and were maintained in groups of 
five in grid-based cages to minimize coprophagy. After 28 d they were housed individually 
in stainless-steel metabolism cages (Acme Metal Co, Chicago, 111, USA), for 24 h to permit 
collection of urine. They were killed by decapitation; blood was collected into heparinized 
vessels on ice and was used immediately for the determination of nicotinamide nucleotides. 
Livers and kidneys were dissected out, frozen in liquid nitrogen within 30 s of decapitation 
and were stored in liquid nitrogen until they were used for the determination of nicotinamide 
nucleotides, and nicotinamide, nicotinic acid and quinolinic acid. The remainder of each 
frozen liver was stored at -20° until it was required for the determination of enzyme 
activities. 
The composition of the diets used is shown in Table 1 ; they were modified from that 
described by Carter el al. (1977). The vitamin mixture provided the recommended amounts 
((US) National Research Council, 1962) of all vitamins except niacin. As described 
previously (Bender, 1980b) the diet was prepared as a jelly, made by dissolving the gelatin 
in warm water, then adding the mixed dry ingredients. This presentation, which was 
accepted well by the animals, simplified the addition of small amounts of tryptophan and 
niacin to the diets, and minimized blockage of the urine-faeces separators of the metabolism 
cages by particles of food. Three diets were used: diet 1 provided no niacin, but 1-9 g of 
tryptophan /kg dry matter (DM); diets 2 and 3 provided 0.9 g tryptophan and 15 mg 
nicotinamide (diet 2) or nicotinic acid (diet 3) /kg DM. These are the (US) National Research 
Council (1962) recommended amounts of niacin for the rat. 
Analytical methods 
Tissue and blood concentrations of total nicotinamide nucleotides (NAD+, NADP+, 
NADH and NADPH) were measured by the following modification of the methods 
described by Kaplan et al. (1951) and Lowry et al. (1961). Approximately 500 mg of tissue 
were homogenized, while still frozen, in 5 ml ice-cold dilute hydrogen peroxide (5 ml 100 
vol. H202/1) to oxidize the reduced nucleotides. This homogenate was mixed immediately 
with 5 ml of a solution of 0.1 M-sodium sulphate in 0.02 M-sulphuric acid, and was heated 
to looo for 5 min. After cooling and centrifugation to remove denatured protein (2000 g, 
15 min), the supernatant fraction was neutralized with 0.2 M-sodium hydroxide. Samples 
of the supernatant fraction (1 ml) were then mixed with 0.5 ml of water, a standard solution 
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Table 1. Composition ( g l k g )  of diets used 
Diet 
I 2 3 
Maize meal 
Gelatin 
Vitamin-free casein 
Maize oil' 
Mineral salt mixture? 
Amino acid mixture1 
Vitamin mixture/[ 
Tryptophan 
Nicotinamide 
Nicotinic acid 
580 
60 
28 
25 
41.1 
9.2 
2 
I g  
I5 mg 
I 5  mg 
Sucrose to 1000 g 
* The following were dissolved in the maize oil to provide (/kg diet): retinol palmitate 10 mg, cholecalciferol 
3 fig, menaphthone 1 mg, a-tocopheryl acetate 75 mg. 
i The mineral salt mixture provided (/kg diet): CaHPO, 18 g, CaCO, 4.5 g, KCI 8.2 g, Na,HPO, 7.4 g, 
MgSO, . H,O 2.8 g, MnSO, .4H,O 361 mg, ferric citrate . 5  H,O 349 mg, ZnCO, 60 mg, CuSO, .5H,O 47 mg, 
KIO, 2 pg. 
The amino acid mixture provided (g/kg diet): Met 2.25, Ile 1.70, Thr 1.50, Lys 1.49, Val 1.10, Cys IGO, Trp 
0.13. 
I/ The vitamin mixture provided (/kg diet): choline bitartrate 1.8 g, calcium pantothenate 40 mg, thiamin 
hydrochloride 10 mg, riboflavin 10 mg, folic acid 5 mg, pyridoxine hydrochloride 1.2 mg, biotin I mg, cyanoco- 
balamin 50 pg, glucose to 2 g. 
of NAD+ (approximately 40 p ~ )  or a solution of NADase from N .  crassa (Sigma Chemical 
Co, Poole, Dorset), containing 30 m-units enzyme activity/ml in 0-2 M-sodium phosphate 
buffer, pH 7.3. The samples containing NADase were then incubated at 37' for 30 min, 
while the others were kept on ice. After the incubation, all samples were mixed with 2 ml 
6 M-NaOH and heated to 100' for 5 min. The fluorescence due to NAD' and NADP+ was 
measured using an Aminco-Bowman spectrophotofluorimeter (activation 360 nm, emission 
460 nm). Preliminary studies (B. I .  Magboul, unpublished results) showed that separate 
internal standards and tissue blanks (in which NAD+ and NADP+ were hydrolysed by 
NADase) were necessary for each sample because of the presence of variable amounts of 
fluorescent material (affecting the tissue blank) and absorbing material (affecting the 
flurorescence yield of the standard) in different samples of tissue. It was also found that 
there was a considerable loss of fluorescence due to nicotinamide nucleotides if the tissue 
was stored for more than approximately 3 h before analysis, even in liquid nitrogen. 
The concentration of nicotinamide nucleotides in blood was measured as follows: 200 pl 
freshly-collected heparinized whole blood was mixed with 200 p1 H,O,, then 2 ml of the acid 
solution of sodium sulphate was added, as described previously. After centrifugation and 
neutralization, 300 ,d samples of the supernatant fraction were treated in the same way as 
the tissue samples. 
The following enzyme activities were measured in samples of liver that had been stored 
at - 20° for up to 3 weeks, by methods that have been described previously (Bender, 1980~): 
quinolinate phosphoribosyltransferase (nicotinate nucleotide : pyrophosphate phosphoribo- 
syltransferase [carboxylating], EC 2 . 4  . 2  . 19), nicotinate phosphoribosyltransferase, 
nicotinamide phosphoribosyltransferase and nicotinamide deamidase. Preliminary studies 
(D. A. Bender, unpublished results) showed that there was no detectable loss of enzyme 
activity on storage at -20' for up to 4 weeks. For the enzyme kinetic studies, livers from 
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animals that had been fed on stock animal-house diet (Diet 18; A. Dixon & Sons, Ware, 
Herts) were used. Enzyme activities were determined as described previously (Bender, 
1980a), using a range of concentrations of substrate, and the values of Michaelis constant 
(K,) and maximum rate of reaction (V,,,) were determined by means of the Lineweaver- 
Burk double-reciprocal plot. Best-fitting lines were estimated by unweighted linear 
regression. 
The concentrations of nicotinamide, nicotinic acid and quinolinic acid in liver were 
determined by the following modification of the method described by Carlson (1966). Tissue 
was stored in liquid nitrogen for up to 3 h after killing, and was then homogenized while 
still frozen in 1 ml ice-cold water/g. A 10 ml sample of the homogenate was immediately 
poured into 60 ml acetone containing 5 ml water or an aqueous solution of nicotinamide, 
nicotinic acid and quinolinic acid, each at a concentration of 1 mM. After mixing, samples 
were left to stand for 30 min with occasional shaking, and were then centrifuged at  2000 g 
for 20 min. The supernatant fraction was extracted twice with 10 ml chloroform, and 
duplicate 3 ml samples of the aqueous phase were evaporated to dryness using a vortex 
evaporator under reduced pressure at 50°. The dry residue from the samples was redissolved 
in 100 pl acetone-water (50 : 50, v/v), and 50 pl samples were applied to the origins of paper 
chromatograms for two-dimensional chromatography. The first solvent was propan-2- 
ol-ammonium hydroxide-water (100 : 5 : 10 v/v); R, values were: nicotinamide 0.80, 
nicotinic acid 0.44, quinolinic acid 0. The second solvent (perpendicular to the first solvent) 
was methanol-pyridine-water (160 : 8 :40 v/v); Rf values were nicotinamide 0.83, nicotinic 
acid 0.81 and quinolinic acid 0.74. Spots corresponding to these compounds were located 
by absorbance under U.V. illumination (254 nm), and were removed. 
Nicotinamide and nicotinic acid were eluted from the paper by boiling in water for 3 h, 
then the volume of the eluate was adjusted to 1.5 ml. Areas of paper containing quinolinic 
acid were heated at 1 roo overnight in 3 ml glacial acetic acid in sealed vials, to elute the 
acid and convert it to nicotinic acid, as described by McDaniel et al. (1973). The acid 
solution was evaporated to dryness in a vortex evaporator under reduced pressure at 50°, 
and the residue was redissolved in 1.5 ml water. Nicotinic acid and nicotinamide were 
measured colorirnetrically (A,,, .,) after reaction with 0.5 ml chloramine T (50 g/l) and 
0.5 ml KCN (10 g/l Tris-HCI) as described by Carlson (1966). Since internal standards of 
nicotinamide, nicotinic acid and quinolinic acid were used, no estimation of the recovery 
of materials through the procedure was performed. In a series of determinations on 
duplicate samples from the same tissue, the mean coefficient of variation was found to be 4% 
for nicotinamide and nicotinic acid and 1 1 % for quinolinic acid. 
Urinary W-methyl nicotinamide was measured by a small-scale modification of the 
fluorimetric method of Carpenter & Kodicek (1950), as described previously (Bender, 
1980 6). 
RESULTS 
The animals maintained on diets 2 and 3 grew less well than those receiving diet I ,  which 
provided no preformed niacin, but contained more tryptophan. All animals weighed 
between 45-55 g on weaning; after 28 d the mean ( ~ s E )  values were (g): diet 1 175f30, 
diet 2 109k24, diet 3 108 k 16. This suggests that tryptophan (and hence protein) may have 
been a limiting factor in diets 2 and 3. 
As can be seen from Table 2, the liver content of nicotinamide nucleotides was 
significantly higher in the animals receiving the high-tryptophan diet than in either of the 
other two groups. The concentrations of nicotinamide nucleotides in blood and kidney were 
not significantly different. The urinary excretion of W-methyl nicotinamide was three times 
higher in the tryptophan-fed animals than in the other two groups. 
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Table 2. Tissue concentrations of nicotinamide nucleotides and precursors, and liver enzyme 
activities in rats fed for 28 d from weaning on diets providing their niacin requirements as 
tryptophan and nicotinamide or nicotinic acid 
(Mean values with pooled standard error, five animals/group) 
Diet no.? 1 2 3 Pooled 
Mean Mean Mean SEM 
Nicotinamide nucleotides: 
Liver @mol/g) 0.58 0.37* 0.37* 0.06 
Kidney @mol/g) 0.36 0.31 0.31 0.05 
Blood (mmol/l) 88.7 82.0 82.8 4.87 
Urine W-methyl nicotinamide @mo1/24 h) 3.3 1.1*** 1.3.'. 0.22 
Quinolinate phosphoribosyltransferase (EC 2.4.2.19) 4.1 3.8 3.7 0.21 
Enzyme activities (nmol/m per g liver): 
Nicotinate phosphoribosyltransferase (EC 2.4.2.11) 0.45 0.33* 0.37; 0.03 
Nicotinamide phosphoribosyltransferase (EC 2.4.2.12) 0.20 0.16 0.18 0.02 
Nicotinamide deamidase (EC 3.5.1 .19) 4.74 4.39 4.39 0.19 
Liver quinolinic acid (nmol/g) 6.2 2.8'- 2.7*** 0.22 
Liver nicotinic acid (nmol/g) 28.7 28.9 32.4* 0.94 
Liver nicotinamide (nmol/g) 758 626* 554*** 33 
Mean values were significantly different from diet 1 ( t  test): *0.05 > P > 0401, ***P < 0401 
t For details of diets, see Table 1. 
Table 3 .  Kinetic measurements of enzymes of nicotinamide nucleotide synthesis in livers 
from rats fed on animal house stock diet 
(Mean values with their standard errors for the replicate determinations) 
V,,,(nmol/min 
Knl01M) SEM per g liver) SEM 
Quinolinate phosphoribosyltransferase 550 36 16 1.3 
Nicotinate phosphoribosyltransferase 24 4 2.5 0.04 
Nicotinamide phosphoribosyltransferase 42 3.6 7.8 0.8 
Nicotinamide deamidase 33 3.6 1.6 2.7 
K,,,, Michaelis constant; V,,,, maximum rate of reaction. 
The enzymes of nicotinamide nucleotide synthesis showed no significant differences with 
diet, except that nicotinate phosphoribosyltransferase was lower in the nicotinamide-fed 
animals than in the other two groups. 
The concentration of quinolinic acid in the livers of the tryptophan-fed animals was 
significantly higher than in the other two groups: the same was true of the liver content 
of nicotinamide, which was lowest in those animals receiving their niacin as nicotinic acid. 
The liver content of nicotinic acid was higher in animals fed on diet 3 than on either of the 
other two diets. 
The values for K ,  of the enzymes measured are shown in Table 3. Nicotinate 
phosphoribosyltransferase was inhibited by its substrate; the inhibitor constant (Ki) for 
nicotinic acid was 1.4 & 0.1 mM, compared with a K, of 24 9 ,UM. 
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DISCUSSION 
The higher liver content of quinolinic acid in animals fed on the high-tryptophan diet is 
to be expected, as is the somewhat higher content of nicotinic acid in the livers of animals 
receiving this precursor in the diet. The liver content of nicotinamide was higher in animals 
receiving this vitamer than in those receiving nicotinic acid, as might be expected; however, 
in the animals fed on the high-tryptophan diet the concentration of nicotinamide in the liver 
was higher than in either of the other two groups. This suggests that there is a considerable 
increase in the flux of substrates through nicotinamide nucleotides, with release of 
nicotinamide from NAD as a result NADase activity. This is supported by the observation 
of a 3-fold hlgher excretion of W-methyl nicotinamide by the tryptophan-fed animals 
compared with either of the other two groups, although the liver content of nicotinamide 
nucleotides was only approximately 56% higher. The enzyme kinetic values shown in 
Table 3, together with the concentrations of substrates in the livers of animals fed on the 
three diets, shown in Table 2, suggest some possible sites of regulation. Both nicotinamide 
deamidase and nicotinamide phosphoribosyltransferase are obviously saturated with 
substrate under normal conditions: the tissue concentration of nicotinamide is more than 
10-fold higher than the K ,  of either enzyme. This suggests that the utilization of 
nicotinamide for nucleotide synthesis will proceed at a more or less constant rate, regardless 
of changes in the availability of nicotinamide. 
Nicotinamide phosphoribosyltransferase appears to act below its V,,,, as the concen- 
tration of nicotinic acid in the liver is less than twice the K ,  of the enzyme. It is therefore 
probable that changes in the availability of nicotinic acid would affect slightly the rate of 
utilization for nucleotide synthesis. However, the magnitude of the change would be 
relatively small, since the tissue concentration of substrate is close to the K ,  of the enzyme. 
Since both nicotinamide deamidase and phosphoribosyltransferase act under conditions 
of substrate availability so much in excess of K,, the small difference in K ,  between the 
two enzymes will not affect the choice of route to be followed by nicotinamide. However, 
the higher V,,, of the deamidase, and the higher activity of the deamidase observed in the 
livers of the animals receiving all three diets, compared with the phosphoribosyltransferase, 
suggest that deamidation may be the more important pathway of nicotinamide utilization, 
assuming that there are no compartmentation effects in vivo. However, it is possible that 
transport of nicotinamide between different cell compartments may be an important factor; 
nicotinamide deamidase is a microsomal enzyme, while the phosphoribosyltransferase was 
measured in the high-speed supernatant fraction of a liver homogenate, and is therefore 
probably a soluble enzyme. 
Delabar & Siess (1979) showed that in isolated guinea-pig atria, nicotinamide was 
apparently incorporated directly into nucleotides when it was present in low concentrations, 
with no exchange of label from [14C]nicotinamide with the tissue-free nicotinic acid. It was 
only when a relatively high concentration of nicotinamide was used that they observed 
significant deamidation to nicotinic acid. Petrack et al. (1965) reported a considerably higher 
value of the K ,  of nicotinamide deamidase than that reported here, apparently due to the 
presence of an endogenous inhibitor which is removed in the partially-purified preparation 
of the enzyme used in this study (Pinder et al. 1971). Hence it is still not possible to decide 
to what extent deamidation or direct incorporation into nucleotides is the major fate of 
nicotinamide in vivo. 
There would appear to be a considerable surplus capacity for the incorporation of 
quinolinic acid into nucleotides; the K ,  of this enzyme is considerably higher than the 
concentration of quinolinic acid in the liver. This suggests that there is no limitation of the 
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ability to incorporate this substrate into nuclotides, and such quinolinic acid as is formed 
from tryptophan will be used for nucleotide synthesis. 
The synthesis of quinolinic acid is controlled largely by the activity of tryptophan 
oxygenase (L-tryptophan : oxygen oxido-reductase, EC 1 .13 .1 .12) ,  the first enzyme of the 
tryptophan oxidative pathway, and by the activity of picolinate carboxylase (3'-0xo- 
prop-2-amino-but-2-ene dioate carboxylase, EC 4 . 1  . 1 .45), which diverts acroleylamino- 
fumarate into the pathway leading to total oxidation. It is only when picolinate carboxylase 
is saturated with its substrate that significant amounts of acroleylaminofumarate accumulate 
and undergo the non-enzymic cyclization to quinolinic acid (Nishizuka & Hayaishi, 1963). 
The activity of tryptophan oxygenase is modified by the availability of tryptophan 
(Greengard & Feigelson, 1961 ; Schimke et al. 1965~)  and the hormonal status of the animal 
(Schimke et al. 1965a, 6). In man the ability to utilize tryptophan as a source of nicotinamide 
nucleotides varies considerably from one individual to another. The widely-quoted equiv- 
alence of 60 mg tryptophan : 1 mg nicotinamide was suggested by Horwitt et al. (1956) to 
ensure an adequate excess to cover the wide range observed in their study. Changes in 
hormonal status that affect tryptophan metabolism, such as pregancy, also affect the 
apparent equivalence of tryptophan and niacin (Wertz ei al. 1958). It thus appears that an 
increase in the rate of tryptophan oxidation will lead to an accumulation of acroleylamino- 
fumarate at a greater rate than it can be metabolized by picolinate carboxylase, leading 
to increased formation of quinolinic acid, and increased formation of nicotinamide 
nucleotides. 
The activity of tryptophan oxygenase is also controlled by feedback inhbition. Wagner 
(1964) showed that both NAD and NADP inhibit the enzyme at a concentration of 5 mM, 
although at lower concentrations he reported no inhibition. Since the total concentration 
of nicotinamide nucleotides observed in the livers of animals in the present study was of 
the order of 0.58 mmol/kg, it is unlikely that feedback inhibition of tryptophan oxygenase 
will be a significant factor in the regulation of tryptophan and niacin metabolism. 
Accumulation of quinolinic acid in the liver has been proposed as one of the mechanisms 
whereby the administration of tryptophan causes hypoglycaemia; quinolinic acid inhibits 
phosphoenolpyruvate carboxykinase (EC 4 . 1  . 1 .49) (Lardy, 1971). This suggests that it 
would be desirable to remove quinolinic acid from the liver as rapidly as possible, so as 
to avoid accumulation. However, the concentration of quinolinic acid, which is inhibitory, 
is some 25-fold higher than that which is observed following acute administration of 
relatively large amounts of tryptophan (McDaniel et al. 1973); Smith et al. (1979) have 
demonstrated induction of phosphoenolpyruvate carboxykinase after administration of 
tryptophan, suggesting that any inhibition will not be physiologically important. 
In the animals receiving the high-tryptophan diet, the liver content of nicotinamide 
nucleotides was approximately 56% higher than in the other two groups of animals, while 
the excretion of W-methyl nicotinamide was approximately 3-fold higher. This suggests that 
there is control of the tissue content of nicotinamide nucleotides by the activity of 
NADase; the nicotinamide released would presumably be subject to the same limitation 
of incorporation into nucleotides as discussed previously, and it is therefore to be expected 
that much would be methylated and excreted as N1-methyl nicotinamide. In this context 
it is interesting to note the observations of Green & Dobrzansky ( 1  967) that administration 
of streptozotocin leads to a severe depletion of tissue NAD, as a result of increased 
hydrolysis to nicotinamide, and this is accompanied by an increase in the excretion of 
"-methyl nicotinamide. Shaikh et al. (1980) have reported that a number of chemical 
carcinogens have a similar effect. It thus seems probable that, as suggested by the present 
kinetic values, the ability to utilize nicotinamide is very limited, and even when tissue levels 
of nucleotides are severely depleted, the nicotinamide released by hydrolysis cannot be 
reutilized. 
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From the present values it would appear that under normal conditions the utilization 
of nicotinamide for synthesis of nucleotides is very strictly controlled and is limited by the 
activity of both nicotinamide deamidase and phosphoribosyltransferase, while the utiliza- 
tion of nicotinic acid may be increased slightly in response to an increase in the availability of 
this vitamer. It seems likely that the utilization of quinolinic acid arising from tryptophan 
is not limited, and that control over the concentrations of nicotinamide nucleotides in tissues 
may be achieved by the action of NADase, with limitation of the reutilization of the 
nicotinamide so released. 
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